Roth Capital Resumes Pieris Pharmaceuticals (PIRS) at Buy

August 5, 2016 8:55 AM EDT
Get Alerts PIRS Hot Sheet
Price: $1.79 -0.56%

Rating Summary:
    3 Buy, 0 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 23 | Down: 34 | New: 34
Trade PIRS Now!
Join SI Premium – FREE

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.

Roth Capital resumed coverage on Pieris Pharmaceuticals (NASDAQ: PIRS) with a Buy rating and a price target of $6.00.

For an analyst ratings summary and ratings history on Pieris Pharmaceuticals click here. For more ratings news on Pieris Pharmaceuticals click here.

Shares of Pieris Pharmaceuticals closed at $1.70 yesterday.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

New Coverage

Related Entities

Roth Capital

Add Your Comment